Evidence for Intravenous Dipyridamole (Persantin) Producing a “Coronary Steal” Effect in the Ischaemic Myocardium
Authors:
- 1 February 1971
- journal article
- clinical trial
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 1 (1) , 8-14
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- MODIFICATION OF THE VASCULAR LESIONS OF REJECTION IN CADAVERIC RENAL ALLOGRAFTS BY DIPYRIDAMOLE AND ANTICOAGULANTSThe Lancet, 1969
- ANTICOAGULANTS IN "IRREVERSIBLE" ACUTE RENAL FAILUREThe Lancet, 1968
- The Effect on Dipyridamole on Platelet Aggregation and AdhesivenessScottish Medical Journal, 1968
- Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve ReplacementNew England Journal of Medicine, 1968
- Effect of a Pyrimidopyrimidine Derivative on Thrombus Formation in the RabbitNature, 1965
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965
- Load, Work, and Velocity of Muscle Shortening of the Left Ventricle in Normal and Abnormal Human Hearts*Journal of Clinical Investigation, 1965
- Influence of a Pyrimidopyrimidine Derivative on Deamination of Adenosine by BloodCirculation Research, 1964
- The relationship between coronary blood flow, myocardial oxygen consumption and cardiac work as influenced by Persantin∗The American Journal of Cardiology, 1962
- Studies with a new coronary vasodilator drug: PersantinAmerican Heart Journal, 1962